Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
मुख्य लेखकों: | Leask, A, Xu, S, Renzoni, E, Bou-Gharios, G, du Bois, R, Abraham, D, Black, C |
---|---|
स्वरूप: | Conference item |
प्रकाशित: |
2005
|
समान संसाधन
-
Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
द्वारा: Shiwen, X, और अन्य
प्रकाशित: (2006) -
Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
द्वारा: S. Soldano, और अन्य
प्रकाशित: (2011-01-01) -
Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
द्वारा: Alix Naert, और अन्य
प्रकाशित: (2013-01-01) -
CTGF overexpressing mice: a model for human scleroderma
द्वारा: Sonnylal, S, और अन्य
प्रकाशित: (2006) -
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
द्वारा: Emma Di Poi, और अन्य
प्रकाशित: (2023-11-01)